Lineage (LINE) reported better-than-expected Q2 results with AFFO per share down 6.2% to $0.76 but raised its full-year AFFO guidance to $2.80–$3.05. The company benefits from strong technological and operational advantages that enhance competitiveness, though it faces risks from high leverage and industry volatility. Long-term supply-demand trends remain favorable, with a potential industry rebound expected by late 2027, supporting a positive investment outlook despite near-term challenges.
Wealthfront Corporation reported better-than-expected Q2 2026 earnings with $0.10 EPS versus $0.08 estimated and revenue of $91.87 million surpassing $91.53 million estimates. The company’s total platform assets grew 12% year-over-year to $99 billion...
Voyageur Pharmaceuticals has reached its first milestone in a collaboration with Bayer by submitting an approved feasibility plan, triggering a $1 million non-dilutive payment. This follows an earlier $350,000 payment, totaling $1.35 million of the $...
Eigen Labs hosted a quantum circuit optimization challenge that outperformed Google's benchmark for breaking Bitcoin and Ethereum cryptography by about 50%. Over 100 participants, including Ethereum Foundation and StarkWare researchers, improved the ...
Vistra Corp. announced a public offering of junior subordinated unsecured notes through its subsidiary, Vistra Operations Company LLC. The proceeds will be used for general corporate purposes, including redeeming some or all of its outstanding prefer...
Shares of memory chip companies like SK Hynix, Micron, and Western Digital dropped significantly despite JPMorgan's Overweight rating and high price target for SK Hynix. The selloff is driven by rising Treasury yields nearing 4.91% and oil prices sur...
